Blood Cancers

>

Latest News

Image of blood cells.
FDA Approves Doptelet With Sprinkle Form for Pediatric Immune Thrombocytopenia

July 25th 2025

Doptelet and new oral sprinkle granules is approved for children one year and older with chronic immune thrombocytopenia, showing 28% durable platelet response in study.

Daniel Jernazian, a two-time cancer survivor, shares what shaped his journey through illness and recovery.
A Survivor and Patient Advocate Reflects on Beating Cancer Twice

July 9th 2025

Image of ribbon
This Wasn’t the Plan: My Mother and Her Silence

July 2nd 2025

Chronic conditions from Waldenström macroglobulinemia can affect quality of life over time.
Survival, Symptoms and Support in Waldenström Macroglobulinemia

July 1st 2025

At age 19, stage 4 blood cancer changed everything, leading to a journey of resilience and quiet hope: © stock.adobe.com.
This Wasn't the Plan: When the World Shifted After Cancer

June 28th 2025

Video Series
Video Interviews
Podcasts
Last week, the FDA provided updates on two cancer therapies. In this episode, we discuss those decisions and more.

More News